No Head-to-Head Trial? Simulate the Missing Arms

被引:74
作者
Caro, J. Jaime [1 ,3 ,4 ]
Ishak, K. Jack [2 ]
机构
[1] United Biosource Corp, Lexington, MA 02420 USA
[2] United BioSource Corp, Dorval, PQ, Canada
[3] McGill Univ, Fac Med, Div Gen Internal Med, Montreal, PQ, Canada
[4] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
关键词
METAANALYSIS; COMBINATION;
D O I
10.2165/11537420-000000000-00000
中图分类号
F [经济];
学科分类号
02 ;
摘要
Establishing efficacy relative to placebo is no longer sufficient for payers to agree to cover new interventions. Evidence from comparisons of competing interventions is increasingly important, although head-to-head studies are seldom available to inform decisions In this article, we describe the simulated treatment comparison (STC) approach to incorporating 'missing arms' into an existing trial. This approach yields a simulated head-to-head trial and can address many of the differences among source trials It provides inputs for economic models and can inform decision makers until actual trial data are available A simulation is constructed to replicate an index trial, including enrolment, randomization and follow-up of patients The simulation is driven by predictive equations derived from the index trial Separate data for the comparators are used to calibrate the index equations to reflect the alternative interventions. The simulation is used to add the missing arms to the index trial and estimate the results that would have been obtained in a head-to-head trial. The STC can also be used to estimate results in various settings and populations and to explore variations in the trial design An STC offers a way to derive comparative effectiveness in the absence of direct trial evidence and a platform to test design features that may help in planning future head-to-head studies
引用
收藏
页码:957 / 967
页数:11
相关论文
共 19 条
[1]   Bayesian methods for evidence synthesis in cost-effectiveness analysis [J].
Ades, AE ;
Sculpher, M ;
Sutton, A ;
Abrams, K ;
Cooper, N ;
Welton, N ;
Lu, GB .
PHARMACOECONOMICS, 2006, 24 (01) :1-19
[2]   The interpretation of random-effects meta-analysis in decision models [J].
Ades, AE ;
Lu, G ;
Higgins, JPT .
MEDICAL DECISION MAKING, 2005, 25 (06) :646-654
[3]  
ADES AE, 2006, JASA, V101, P447
[4]  
ALBERTI W, 1995, BRIT MED J, V311, P899
[5]  
Brattström L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894
[6]   Pharmacoeconamic analyses using discrete event simulation [J].
Caro, JJ .
PHARMACOECONOMICS, 2005, 23 (04) :323-332
[7]  
CARO JJ, VALUE HLTH IN PRESS
[8]  
Kelton WD., 2007, Simulation with Arena, V4th
[9]   Combination of direct and indirect evidence in mixed treatment comparisons [J].
Lu, G ;
Ades, AE .
STATISTICS IN MEDICINE, 2004, 23 (20) :3105-3124
[10]   Network meta-analysis for indirect treatment comparisons [J].
Lumley, T .
STATISTICS IN MEDICINE, 2002, 21 (16) :2313-2324